DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Indobufen

Indobufen

  • (12) United States Patent (10) Patent No.: US 9,498,481 B2 Rao Et Al

    (12) United States Patent (10) Patent No.: US 9,498,481 B2 Rao Et Al

  • Characterising the Risk of Major Bleeding in Patients With

    Characterising the Risk of Major Bleeding in Patients With

  • )&F1y3x PHARMACEUTICAL APPENDIX to THE

    )&F1y3x PHARMACEUTICAL APPENDIX to THE

  • Anticoagulant Activities of Indobufen, an Antiplatelet Drug

    Anticoagulant Activities of Indobufen, an Antiplatelet Drug

  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

    Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

  • Section B Changed Classes/Guidelines Final

    Section B Changed Classes/Guidelines Final

  • (12) United States Patent (10) Patent No.: US 8,080,578 B2 Liggett Et Al

    (12) United States Patent (10) Patent No.: US 8,080,578 B2 Liggett Et Al

  • Supplemental Material Liu Page 1

    Supplemental Material Liu Page 1

  • Meta-Regression of Randomized Control Trials with Antithrombotics

    Meta-Regression of Randomized Control Trials with Antithrombotics

  • ( 12 ) United States Patent

    ( 12 ) United States Patent

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Indobufen a Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in Cerebral, Peripheral and Coronary Vascular Disease

    Indobufen a Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in Cerebral, Peripheral and Coronary Vascular Disease

  • United States Patent (19) 11 Patent Number: 5,916,910 Lai (45) Date of Patent: Jun

    United States Patent (19) 11 Patent Number: 5,916,910 Lai (45) Date of Patent: Jun

  • Aspirin in Coronary Artery Disease an Appraisal of Functions and Limitations

    Aspirin in Coronary Artery Disease an Appraisal of Functions and Limitations

  • 5051881.Pdf (2.227Mb)

    5051881.Pdf (2.227Mb)

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • An Open-Label, Multicenter, Expanded Access Study Of

    An Open-Label, Multicenter, Expanded Access Study Of

  • Head Injury Partial Update

    Head Injury Partial Update

Top View
  • Management of Antithrombotic Drugs in Association with Endoscopic
  • Appendix: Drug Dosing in Renal Failure
  • Reproductive Health Guideline Appendix 3 – Search Strategies
  • Non-Steroidal Anti-Inflammatory Drug Effects on Core Temperature
  • 8-11 January 2018 PRAC Meeting Minutes
  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
  • Systemic Glucocorticoids in the Treatment of COVID-19 and Risks of Adverse Outcomes in COVID-19 Patients in the Primary and Secondary Care Setting
  • Marrakesh Agreement Establishing the World Trade Organization
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Prezentacja Programu Powerpoint
  • Risk Markers for Cardiovascular Disease in Patients with Chronic Kidney Disease
  • Review of Atrial Fibrillation Outcome Trials of Oral Anticoagulant And
  • Customs Tariff - Schedule
  • Pharmaceutical Compositions Comprising Prasugrel And
  • ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
  • ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
  • Customs Tariff - Schedule Xxi - 1
  • Australian Statistics on Medicines 2009


© 2024 Docslib.org    Feedback